Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial
| Image |  |
|---|---|
| Description | scientific article published on 04 April 2019 |
| Author/s |
author: Andrea Casadei Gardini Imam Waked |
| Publication date | April 4, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |